| Name | Utah Eye Centers |
|---|---|
| Organization Name | Mt Ogden Eye Center Llc |
| Location | 214 W 1500 S, Ste 300, Bountiful, Utah 84010 |
| Type | Supplier |
| Phone | (801) 476-0494 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mylan N.V. today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the cancerous cells.
The Wall Street Journal: A crop of websites to help patients store medical information and monitor their health are gaining attention. "With people over 50 increasingly focused on ways to monitor and measure their health, [online personal health records, or PHRs] are drawing more attention. In addition to Microsoft Corp.'s [HealthVault], other well-known PHRs include Google Inc.'s Google Health and WebMD Health Manager from WebMD Health Corp.
› Verified 6 days ago
News Archive
Mylan N.V. today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the cancerous cells.
The Wall Street Journal: A crop of websites to help patients store medical information and monitor their health are gaining attention. "With people over 50 increasingly focused on ways to monitor and measure their health, [online personal health records, or PHRs] are drawing more attention. In addition to Microsoft Corp.'s [HealthVault], other well-known PHRs include Google Inc.'s Google Health and WebMD Health Manager from WebMD Health Corp.
› Verified 6 days ago
Walgreens #6183 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 515 S 500 W, Bountiful, Utah 84010 Phone: (801) 294-9107 | |
Dicks Family Pharmacy Type: Community/Retail Pharmacy Location: 2280 Orchard Dr, Bountiful, Utah 84010 Phone: (801) 296-2222 | |
Smith's Pharmacy #444 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 555 S 200 W, Bountiful, Utah 84010 Phone: (801) 397-7833 | |
Bountiful Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 47 E 500 S, Bountiful, Utah 84010 Phone: (801) 295-3463 | |
Integrated Functional Medicine Type: Durable Medical Equipment & Medical Supplies Supplier Location: 458 N 500 W, Bountiful, Utah 84010 Phone: (801) 292-9355 |